These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16203660)

  • 1. The androgen receptor and mechanisms for androgen independence in prostate cancer.
    Javidan J; Deitch AD; Shi XB; de Vere White RW
    Cancer Invest; 2005; 23(6):520-8. PubMed ID: 16203660
    [No Abstract]   [Full Text] [Related]  

  • 2. [The mechanism of hormone-independent recurrence of prostate cancer].
    Fukabori Y
    Nihon Rinsho; 2000 Jul; 58 Suppl():45-52. PubMed ID: 11022683
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of androgen receptor signaling in prostate cancer.
    Dehm SM; Tindall DJ
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):63-74. PubMed ID: 15757439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in understanding androgen-independent prostate cancer (AIPC): a review of potential endocrine-mediated mechanisms.
    Schröder FH
    Eur Urol; 2008 Jun; 53(6):1129-37. PubMed ID: 18262723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biology of castration-recurrent prostate cancer.
    Azzouni F; Mohler J
    Urol Clin North Am; 2012 Nov; 39(4):435-52. PubMed ID: 23084522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prostate cancer and androgen].
    Komiya A; Ito H
    Nihon Rinsho; 2000 Jul; 58 Suppl():35-40. PubMed ID: 11022681
    [No Abstract]   [Full Text] [Related]  

  • 7. Human prostate cancer (PC-82) in nude mice: a model to study androgen regulated tumor growth.
    van Steenbrugge GJ; Groen M; Bolt-de Vries J; Romijn JC; Schroeder FH
    Prog Clin Biol Res; 1985; 185A():23-50. PubMed ID: 4034577
    [No Abstract]   [Full Text] [Related]  

  • 8. [Development and progression of prostate cancer in relation with androgen dependency].
    Shimazaki J
    Nihon Rinsho; 1998 Aug; 56(8):1953-8. PubMed ID: 9750486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms underlying the development of androgen-independent prostate cancer.
    Pienta KJ; Bradley D
    Clin Cancer Res; 2006 Mar; 12(6):1665-71. PubMed ID: 16551847
    [No Abstract]   [Full Text] [Related]  

  • 10. The development of androgen-independent prostate cancer.
    Feldman BJ; Feldman D
    Nat Rev Cancer; 2001 Oct; 1(1):34-45. PubMed ID: 11900250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of IGFBP-3 by the androgen receptor in the lineage-related androgen-dependent LNCaP and androgen-independent C4-2 prostate cancer models.
    Kojima S; Mulholland DJ; Ettinger S; Fazli L; Nelson CC; Gleave ME
    Prostate; 2006 Jun; 66(9):971-86. PubMed ID: 16541420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical evaluation of the use of androgen receptor assays to predict the androgen responsiveness of prostatic cancer.
    Barrack ER; Tindall DJ
    Prog Clin Biol Res; 1987; 239():155-87. PubMed ID: 3309954
    [No Abstract]   [Full Text] [Related]  

  • 13. GREB1 is a novel androgen-regulated gene required for prostate cancer growth.
    Rae JM; Johnson MD; Cordero KE; Scheys JO; Larios JM; Gottardis MM; Pienta KJ; Lippman ME
    Prostate; 2006 Jun; 66(8):886-94. PubMed ID: 16496412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The convergence of hormone regulation and cell cycle in prostate physiology and prostate tumorigenesis.
    Davis JN; Day ML
    Mol Biotechnol; 2002 Oct; 22(2):129-38. PubMed ID: 12405261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stepping-stones to the further advancement of androgen-deprivation therapy for prostate cancer.
    Nishiyama T; Suzuki K; Yamana K; Tonegawa E; Wako K; Takahashi K
    Expert Rev Anticancer Ther; 2006 Feb; 6(2):259-68. PubMed ID: 16445378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine disrupting compounds and prostate cancer.
    Hess-Wilson JK; Knudsen KE
    Cancer Lett; 2006 Sep; 241(1):1-12. PubMed ID: 16298040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of prostate cancer progression to androgen independence.
    McPhaul MJ
    Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):373-88. PubMed ID: 18471793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone treatment for prostate cancer: current issues and future directions.
    Ichikawa T; Suzuki H; Ueda T; Komiya A; Imamoto T; Kojima S
    Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():58-63. PubMed ID: 16273367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Context-dependent hormone-refractory progression revealed through characterization of a novel murine prostate cancer cell line.
    Watson PA; Ellwood-Yen K; King JC; Wongvipat J; Lebeau MM; Sawyers CL
    Cancer Res; 2005 Dec; 65(24):11565-71. PubMed ID: 16357166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways.
    Vis AN; Schröder FH
    BJU Int; 2009 Aug; 104(4):438-48. PubMed ID: 19558559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.